Skip to main content
OpenTrials
Completed

NCT Number: NCT03516552

Comparison and Analysis of Blood Loss Formulas

Although it has been pointed that estimates are significantly inexact and different from each other, the actual accuracy of them has not been properly investigated and compared.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Loss Hemorrhage Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Clinic de Barcelona

Barcelona, 08036, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adults 18 - 90 yrs.

Exclusion criteria

  • Suspected or confirmed coagulopathy (including current treatment with anticoagulants or antiplatelet agents).
  • Surgical blood loss volume < 200 ml.
  • Requirement for surgical gauzes during surgery, including conversion to open surgical techniques.
  • Transfusion of red blood cells (RBCs) during the perioperative period.
  • Significant postoperative bleeding (> 50 ml in surgical drains) or any other type of significant blood loss.
  • Fluid infusions or vasoactive drugs after the first 24 postoperative hours.

Treatment and study plan

Primary outcomes

  1. Differences on blood loss estimation.

    Time frame: 72 hours.

Sponsors and collaborators

Lead sponsor

Hospital Clinic of Barcelona

Other

Registry information

Important dates

Study start
2018
Primary completion
2018
Study completion
2018
First posted
May 4, 2018
Registry last updated
Aug 7, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.